Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MOREPEN LABS vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 MOREPEN LABS   MYLAN
EQUITY SHARE DATA
    MOREPEN LABS
Mar-23
MYLAN
Dec-18
MOREPEN LABS/
MYLAN
5-Yr Chart
Click to enlarge
High Rs553,972-   
Low Rs242,186-   
Sales per share (Unadj.) Rs27.71,827.6-  
Earnings per share (Unadj.) Rs0.849.6-  
Cash flow per share (Unadj.) Rs1.3391.8-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs14.71,977.1-  
Shares outstanding (eoy) m511.17514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.41.7 84.0%   
Avg P/E ratio x51.862.0 83.6%  
P/CF ratio (eoy) x30.17.9 383.1%  
Price / Book Value ratio x2.71.6 171.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m20,0511,584,113 1.3%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m1,5470-   
Avg. sales/employee Rs Th026,865.3-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0729.5-  
INCOME DATA
Net Sales Rs m14,175940,285 1.5%  
Other income Rs m610-   
Total revenues Rs m14,237940,285 1.5%   
Gross profit Rs m795243,311 0.3%  
Depreciation Rs m279176,058 0.2%   
Interest Rs m2045,224 0.0%   
Profit before tax Rs m55822,028 2.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m171-3,504 -4.9%   
Profit after tax Rs m38725,533 1.5%  
Gross profit margin %5.625.9 21.7%  
Effective tax rate %30.6-15.9 -192.6%   
Net profit margin %2.72.7 100.5%  
BALANCE SHEET DATA
Current assets Rs m7,562525,055 1.4%   
Current liabilities Rs m3,212382,823 0.8%   
Net working cap to sales %30.715.1 202.9%  
Current ratio x2.41.4 171.7%  
Inventory Days Days1884 21.7%  
Debtors Days Days67893 726.4%  
Net fixed assets Rs m3,543182,400 1.9%   
Share capital Rs m1,022501 204.2%   
"Free" reserves Rs m6,5070-   
Net worth Rs m7,5291,017,217 0.7%   
Long term debt Rs m91,097,904 0.0%   
Total assets Rs m11,1052,728,571 0.4%  
Interest coverage x29.11.5 1,959.9%   
Debt to equity ratio x01.1 0.1%  
Sales to assets ratio x1.30.3 370.4%   
Return on assets %3.72.6 141.2%  
Return on equity %5.12.5 204.7%  
Return on capital %7.73.2 240.9%  
Exports to sales %39.90-   
Imports to sales %30.50-   
Net fx Rs m1,2130-   
CASH FLOW
From Operations Rs m-912195,391 -0.5%  
From Investments Rs m-465-100,996 0.5%  
From Financial Activity Rs m1,435-91,025 -1.6%  
Net Cashflow Rs m591,619 3.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.44 Rs / USD

Compare MOREPEN LABS With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare MOREPEN LABS With: UNICHEM LAB  SHUKRA PHARMA  MANGALAM DRUGS  ZENOTECH LABS  AARTI DRUGS  



Today's Market

Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9% Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9%(Closing)

After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.